58th Annual Neurology Update and Stroke Intensive Review 2025

58th Annual Neurology Update and Stroke Intensive Review 2025 is organized by University of Miami Miller School of Medicine Division of Continuing Medical Education and will be held from Mar 06 - 08, 2025 at Loews Coral Gables Hotel, Coral Gables, Florida, United States of America.

Description:
The 58th Annual Neurology Update and Stroke Intensive Review 2025 provides clinicians with a comprehensive review of the most recent developments in the diagnosis and management of neurologic disorders, including stroke, cognitive neurology/brain health, epilepsy, multiple sclerosis (MS), movement disorders, neuromuscular disorders, headache/migraine, neuro-oncology, sleep disorders and general neurology.

Challenging diagnostic and therapeutic questions will be raised in each session around representative clinical vignettes, targeted reviews of the topic by the faculty and panel discussions. Exchange of information between faculty and attendees will take place during questions and answers sessions after each presentation as well as round table and panel discussions.

What's New This Year: Saturday Nursing Symposium

Stroke Seminar:
A dedicated stroke seminar will take place Saturday, designed as a stand-alone 8-hour CME activity. For those centers planning to seek stroke center status or already designated as a stroke center, this course will provide stroke teams with the most up-to-date evidence in the field of stroke diagnosis, treatment and prevention.

Overall Educational Objectives:
At the completion of the course, attendees will be able to:

Cognitive Neurology

• Evaluate recently approved amyloid-targeting therapies for early Alzheimer's Disease
• Define amyloid related imaging abnormalities and identify symptoms and treatment recommendations
• Examine emerging treatments and their proposed mechanisms of action
• Assess advances in blood-based biomarkers to diagnose Alzheimer's Disease
• Evaluate advances in spinal fluid and skin biopsy analyses to diagnose Lewy Body Dementia
• Define incorporation of new biomarkers into clinical practice and their appropriate use

Epilepsy 

• Prescribe the newest third generation antiseizure medications for the treatment of focal and generalized epilepsy and Lennox Gastaut Syndrome
• Recognize when neuromodulation therapies with Deep Brain Stimulation and   Responsive Neurostimulation are indicated for the treatment of refractory epilepsy
• Select patients with temporal lobe epilepsy who can be ideal candidates for laser ablation of mesial temporal structures

Headache/Migraine 

• Evaluate strategies and guidelines for managing migraine headache disorder in women across the lifespan, with focus on menstrual migraine, pregnancy and breastfeeding, and menopause
• Identify common diagnostic and therapeutic challenges and solutions in patients with cluster headache disorder and other trigeminal autonomic cephalalgias
• Examine the clinical implications of medication overuse for headache and the strategies for identification and management
• Assess the updates in headache medicine over the past year, including clinical pearls for implementation into clinical practice

Movement Disorders

• Present the latest diagnostic criteria and treatments for Parkinson’s disease
• Outline the motor and nonmotor fluctuations that complicate Parkinson’s   disease symptoms.
• Delineate the diagnosis and treatment of ET and its mimickers

Multiple Sclerosis 

• Improve diagnostic accuracy based on the most current criteria for diagnosis of multiple sclerosis 
• Assess the MRI criteria for diagnosis of MS using the most appropriate and current sequences
• Examine Brutontyrosine Kinase (BTK) inhibitors as the future therapy for MS 

Neuro-Oncology 

• Evaluate the role of the general neurologist in the care of patients with primary and secondary brain tumors
• Explain the advances in Neuro-Oncology in the last year
• Assess the role of new therapies in treating brain tumor patients

Neuromuscular Disorders

• Outline gaps in amyotrophic lateral sclerosis (ALS) diagnosis and treatment
• Recognize early genetic testing as an opportunity to make an early diagnosis as a familial ALS and identify Tofersen as a promising new treatment for genetic forms of ALS and as a model for future genetic treatments
• Describe the utility of following regular serologic neurofilament light chain (NfL) levels as a treatment response
• Distinguish myelitis/radiculitis side effects from ALS using the identification of pain, sensory abnormalities, and rapidly progressive weakness
• Identify common clinical scenarios where electrodiagnostic (EDX) testing is essential for diagnosing nerve injuries, determining prognosis and surgical planning
• Describe how EDX results can influence prognostic expectations of nerve recovery and analyze the advantages of electrodiagnostic in enhancing surgical planning, as well as the limitations and pitfalls 
• Illustrate how EDX testing can complement other diagnostic approaches (i.e. clinical examination, MRI, US)
• Identify the causes of mononeuritis multiplex (MNM)
• Clinically suspect vasculitis neuropathy
• Assess the potential long-term complications of MNM, including nerve damage, disability, and the risk of recurrence
• Develop strategies to track the progression of nerve damage over time and intervene early to prevent further deterioration
• Outline the management strategies for patients with MNM

Sleep Disorders

• Recognize the importance of sleep, sleep dimensions, and sleep hygiene
• Define the sleep processes including sleep drive and circadian rhythm
• Demonstrate awareness about the pathophysiology and consequences of sleep disorders
• Characterize new technologies in diagnosis and treatment of sleep disorders
• Describe treatment approaches for sleep disorders

Stroke

• Treat appropriate acute ischemic stroke patients with modern strategies that   include the extended 24-hour treatment window with thrombolytics,   endovascular approaches and antithrombotic
• Establish appropriate management of intracerebral hemorrhage according to current guidelines for the management of hypertensive and lobar hemorrhages as well as the role of reversal strategies in coagulopathic hemorrhages
• Institute measures to prevent a recurrent stroke based on stroke mechanisms and in special populations according to the most recent guidelines and evidence